GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » Additional Paid-In Capital

Prism Biolab Co (TSE:206A) Additional Paid-In Capital : 円3,345.4 Mil(As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co Additional Paid-In Capital?


Prism Biolab Co's quarterly additional paid-in capital increased from Mar. 2024 (円2,378.6 Mil) to Sep. 2024 (円3,330.8 Mil) and increased from Sep. 2024 (円3,330.8 Mil) to Mar. 2025 (円3,345.4 Mil).

Prism Biolab Co's annual additional paid-in capital stayed the same from Sep. 2022 (円1,628.6 Mil) to Sep. 2023 (円1,628.6 Mil) but then increased from Sep. 2023 (円1,628.6 Mil) to Sep. 2024 (円3,330.8 Mil).


Prism Biolab Co Additional Paid-In Capital Historical Data

The historical data trend for Prism Biolab Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co Additional Paid-In Capital Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
Additional Paid-In Capital
1,628.57 1,628.57 3,330.77

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24 Mar25
Additional Paid-In Capital 1,628.57 1,628.57 2,378.57 3,330.77 3,345.36

Prism Biolab Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Prism Biolab Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines